EntryPoint Capital’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

EntryPoint Capital’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-349	Closed	-$7.44K	–	1762
2024 Q1	$7.44K	Buy	+349	New	+$4.17K	0.01%	1272

EntryPoint Capital's FUSN Position: Q2 2024 in Review

EntryPoint Capital sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 349 shares — an estimated $7.44K sold.

EntryPoint Capital first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $7.44K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

EntryPoint Capital reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
EntryPoint Capital sold 349 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $7.44K.
EntryPoint Capital first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
EntryPoint Capital's Fusion Pharmaceuticals Inc. Common Shares position peaked at $7.44K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.